Advertisement

Index by author

October 01, 1995; Volume 275,Issue 1

  1. Hossain, M A

    1. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
      M A Hossain and N Weiner
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 237-244;

  2. Howard, H R

    1. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
      T F Seeger, P A Seymour, A W Schmidt, S H Zorn, D W Schulz, L A Lebel, S McLean, V Guanowsky, H R Howard and J A Lowe
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 101-113;

  3. Ijzerman, A P

    1. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
      R A Mathôt, J M Gubbens-Stibbe, W Soudijn, K A Jacobson, A P Ijzerman and M Danhof
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 245-253;

  4. Imamura, Y

    1. Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy.
      Y Imamura and G J Bennett
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 177-182;

  5. Ingelman-sundberg, M

    1. Phenethyl isothiocyanate, a new dietary liver aldehyde dehydrogenase inhibitor.
      K O Lindros, T Badger, M Ronis, M Ingelman-Sundberg and M Koivusalo
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 79-83;

  6. Ishihara, F

    1. Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.
      T Aizawa, N Taguchi, Y Sato, T Nakabayashi, H Kobuchi, H Hidaka, T Nagasawa, F Ishihara, N Itoh and K Hashizume
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 194-199;

  7. Ishii, T

    1. Necessity of newly synthesized ATP by creatine kinase for contraction of permeabilized longitudinal muscle preparations of rat proximal colon.
      T Takeuchi, A Fujita, T Ishii, H Nishio and F Hata
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 429-434;

  8. Itoh, N

    1. Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.
      T Aizawa, N Taguchi, Y Sato, T Nakabayashi, H Kobuchi, H Hidaka, T Nagasawa, F Ishihara, N Itoh and K Hashizume
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 194-199;

  9. Jacobson, K A

    1. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
      R A Mathôt, J M Gubbens-Stibbe, W Soudijn, K A Jacobson, A P Ijzerman and M Danhof
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 245-253;

  10. Jenck, F

    1. Comparison of benzodiazepine receptor ligands with partial agonistic, antagonistic or partial inverse agonistic properties in precipitating withdrawal in squirrel monkeys.
      J R Martin, F Jenck and J L Moreau
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 405-411;
« Previous (Pages : 6 7 8 9 10 11 12 13 14 15 ... 27) Next »
Back to top

In this issue

Advertisement